Initial results of the Quanam drug eluting stent (QuaDS-QP-2) Registry (BARDDS) in human subjects.

Abstract

Thirty-two patients presenting with varied coronary syndromes and anatomy were treated with a new coronary multisleeve drug delivery coronary stent (QuaDS-QP-2) containing up to 4,000 microg of a taxol-derived lipophilic microtubule inhibitor (QP2). The device was successfully implanted in 32 patients who have been followed for up to 2 years. Twenty-five… (More)

Topics

Cite this paper

@article{Fuente2001InitialRO, title={Initial results of the Quanam drug eluting stent (QuaDS-QP-2) Registry (BARDDS) in human subjects.}, author={Luis M de la Fuente and Jorge A Miano and Jad Mrad and Eduardo Rommel Oliv{\^e}ncia Pe{\~n}aloza and Alan Yeung and R Eury and M Froix and Peter Fitzgerald and Simon H. Stertzer}, journal={Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions}, year={2001}, volume={53 4}, pages={480-8} }